SPY is an exchange-traded fund (ETF) that aims to replicate the performance of the S&P 500 Index. The S&P 500 Index includes 500 of the largest publicly traded companies in the United States, representing a broad cross-section of the U.S. economy.
Metrics and analysis →XBI
XBI, or SPDR S&P Biotech ETF, is an exchange-traded fund (ETF) that aims to provide investment results that correspond to the performance of the S&P Biotechnology Select Industry Index. It focuses on biotechnology companies and provides exposure to a broad range of firms within the biotech sector.
- Open
- 143.00
- High
- 145.50
- Low
- 139.87
- Prev close
- 144.12
- Volume
- 8M
- Avg vol 10
- 8M
Today · Market closed · opens Mon 9:30 AM
XBI chart
Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history
Technical analysis
Daily bars · last bar Nov 20, 2026 · close 140.99
Leaning sell. 8 of 18 signals point down against 4 up, carried by momentum and trend. Volatility leans buy. Volume is mostly neutral. Stochastic, Stoch RSI, Williams %R and CCI sit in oversold territory. Trend strength is weak (ADX 15).
Trend
Momentum
Volatility
Volume
Strong sell. The close is above 1 of 24 averages and below 23. Short- and long-term averages agree: price is below both. SMA 50 is above SMA 200 (152.73 vs 143.45).
| Period | SMA | EMA | WMA | WEMA |
|---|---|---|---|---|
| 5 | 144.26 | 144.58 | 143.53 | 146.88 |
| 10 | 149.13 | 147.30 | 146.42 | 149.56 |
| 20 | 151.73 | 149.72 | 149.70 | 151.63 |
| 50 | 152.73 | 152.14 | 151.41 | 151.07 |
| 100 | 155.46 | 150.98 | 154.14 | 143.53 |
| 200 | 143.45 | 142.51 | 149.95 | 132.32 |
Green: the close is above that average. Red: below it.
From the bar before the last one. Nearest classic support is S2 at 140.21. Nearest resistance is S1 at 142.16.
| Level | Classic | Fibonacci | Camarilla | Floor | Woodie | DeMark |
|---|---|---|---|---|---|---|
| R3 | 156.23 | 150.89 | 145.59 | 152.84 | 150.89 | — |
| R2 | 150.89 | 148.85 | 145.10 | 150.89 | 149.91 | — |
| R1 | 147.50 | 147.59 | 144.61 | 147.50 | 145.55 | 146.53 |
| Pivot | 145.55 | 145.55 | 145.55 | 145.55 | 144.57 | 145.06 |
| S1 | 142.16 | 143.51 | 143.63 | 142.16 | 140.21 | 141.19 |
| S2 | 140.21 | 142.25 | 143.14 | 140.21 | 139.23 | — |
| S3 | 134.87 | 140.21 | 142.65 | 136.82 | 134.87 | — |
Patterns that formed on the last 5 bars, newest first.
An engulfing pattern (a candle swallowing the one before) followed by a third candle that closes further the same way.
A confirmed engulfing: a turn down from an advance.
A candle whose body completely covers the body of the one before it, in the opposite colour.
Sellers overwhelmed the previous session's buying; after an advance a turn down may follow.
A small body with shadows longer than the body on both sides.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
A long candle with no shadow at the close: it closed at its high (bullish) or its low (bearish).
Sellers held control into the close.
How candlestick references usually rate the pattern. It is not a success rate measured on this ticker. About candle patterns
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| Nov 20, 2026 | 142.88 | 145.50 | 139.87 | 140.99 | 9M | −1.89 |
| Nov 19, 2026 | 145.38 | 148.93 | 143.59 | 144.12 | 13M | −1.26 |
| Nov 18, 2026 | 144.86 | 147.61 | 144.40 | 145.04 | 4M | +0.18 |
| Nov 17, 2026 | 147.07 | 147.72 | 143.24 | 145.28 | 8M | −1.79 |
| Nov 16, 2026 | 150.01 | 151.34 | 145.50 | 145.88 | 11M | −4.13 |
| Nov 13, 2026 | 151.24 | 151.31 | 148.17 | 150.55 | 8M | −0.69 |
| Nov 12, 2026 | 154.35 | 154.51 | 150.50 | 151.20 | 9M | −3.15 |
| Nov 11, 2026 | 155.85 | 156.89 | 154.73 | 156.31 | 6M | +0.46 |
| Nov 10, 2026 | 155.22 | 157.85 | 153.22 | 155.06 | 7M | −0.16 |
| Nov 9, 2026 | 153.21 | 157.92 | 151.00 | 156.90 | 9M | +3.69 |
| Nov 6, 2026 | 148.82 | 152.92 | 147.56 | 152.21 | 11M | +3.39 |
| Nov 5, 2026 | 157.45 | 157.61 | 148.25 | 148.40 | 14M | −9.05 |
| Nov 4, 2026 | 158.35 | 159.33 | 152.65 | 159.10 | 12M | +0.75 |
| Nov 3, 2026 | 152.96 | 156.92 | 152.83 | 154.97 | 6M | +2.01 |
| Nov 2, 2026 | 156.41 | 157.12 | 151.69 | 152.05 | 8M | −4.36 |
| Oct 30, 2026 | 156.68 | 159.76 | 154.22 | 155.98 | 9M | −0.70 |
| Oct 29, 2026 | 157.64 | 160.29 | 156.43 | 157.79 | 11M | +0.15 |
| Oct 28, 2026 | 153.27 | 157.55 | 152.83 | 157.51 | 9M | +4.24 |
| Oct 27, 2026 | 150.35 | 154.92 | 149.27 | 154.84 | 9M | +4.49 |
| Oct 26, 2026 | 150.42 | 151.83 | 149.49 | 150.47 | 5M | +0.05 |
| Oct 23, 2026 | 150.46 | 150.71 | 147.64 | 149.54 | 7M | −0.92 |
| Oct 22, 2026 | 152.25 | 154.44 | 149.69 | 151.64 | 12M | −0.61 |
| Oct 21, 2026 | 153.37 | 155.78 | 152.69 | 152.78 | 8M | −0.59 |
| Oct 20, 2026 | 148.03 | 153.98 | 147.75 | 153.24 | 12M | +5.21 |
| Oct 19, 2026 | 145.88 | 148.63 | 145.29 | 147.86 | 8M | +1.98 |
| Oct 16, 2026 | 149.89 | 150.23 | 143.85 | 144.32 | 12M | −5.57 |
| Oct 15, 2026 | 147.71 | 150.86 | 146.93 | 149.78 | 12M | +2.07 |
| Oct 14, 2026 | 146.17 | 148.82 | 145.26 | 146.77 | 10M | +0.60 |
| Oct 13, 2026 | 150.52 | 150.89 | 146.70 | 146.80 | 10M | −3.72 |
| Oct 12, 2026 | 153.43 | 154.12 | 151.10 | 151.40 | 6M | −2.03 |
Performance
Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures
1 month return
-7.56%
Change in value over the past month.
3 month return
-14.61%
Change in value over the last three months.
Max drawdown
17.32%
Largest fall from a peak to the low that followed.
Standard deviation
31.14%
How far daily returns stray from their average, annualised.
Sharpe ratio
0.67
Return above the risk-free rate per unit of volatility.
Calmar ratio
1.21
Annualised return against the maximum drawdown.
XBI summary
Loading summary…
XBI, answered
How can I invest in XBI?
Investors can purchase shares of XBI through a brokerage account. It is traded on major stock exchanges under the ticker symbol "XBI" and can be bought and sold like other stocks and ETFs.
How does XBI handle index rebalancing or changes?
XBI adjusts its holdings to reflect changes in the S&P Biotechnology Select Industry Index. The ETF rebalances periodically to ensure it continues to accurately track the index, incorporating any changes in index composition or weighting.
What factors can affect the performance of XBI?
Factors influencing XBI’s performance include biotech industry trends, regulatory changes, clinical trial outcomes, market sentiment, and broader economic conditions. The ETF’s performance is also affected by the performance of the underlying index.
What is the historical performance of XBI?
Historical performance data for XBI includes past returns, NAV, and volatility. Investors can review performance charts and reports to assess how XBI has tracked its index and how its value has changed over time.
What are the key performance metrics for XBI?
Key performance metrics for XBI include its net asset value (NAV), expense ratio, average daily trading volume, and total return over various periods (e.g., 1-year, 5-year). NAV reflects the per-share value of the ETF, while total return measures the performance of the fund.
Can XBI be used in a retirement account?
Yes, XBI can be held in retirement accounts such as IRAs or 401(k)s. It is important to consider how it fits within your overall investment strategy and risk tolerance given its focus on the biotech sector.
How often does XBI distribute dividends?
XBI typically distributes dividends on a quarterly basis. These dividends are generated from income produced by the underlying securities in the ETF.
How is XBI managed?
XBI is managed by State Street Global Advisors and tracks the S&P Biotechnology Select Industry Index. The ETF is passively managed, meaning it seeks to replicate the performance of the index by holding the same securities in similar proportions.
What are the risks associated with investing in XBI?
Risks include high volatility and sector-specific risks associated with biotechnology companies. The biotech sector can be highly sensitive to regulatory changes, clinical trial results, and market sentiment, which can lead to significant fluctuations in XBI’s value.
What is the expense ratio of XBI?
XBI has an expense ratio of approximately 0.35%. This fee represents the cost of managing the fund, including administrative and operational expenses, and is expressed as a percentage of the fund’s average net assets.
XBI in the news
Top market assets
Discover our curated selection of top-performing exchange-traded funds (ETFs) that represent a diverse range of investment opportunities.
QQQ is an exchange-traded fund (ETF) that tracks the performance of the Nasdaq-100 Index. This index includes 100 of the largest non-financial companies listed on the Nasdaq Stock Market, primarily focusing on technology and innovation sectors.
Metrics and analysis →DIA is an exchange-traded fund (ETF) that aims to track the performance of the Dow Jones Industrial Average (DJIA). The DJIA is a stock market index consisting of 30 large, publicly traded companies in the United States, representing a broad range of industries.
Metrics and analysis →IWM is an exchange-traded fund (ETF) that seeks to track the performance of the Russell 2000 Index. The Russell 2000 Index measures the performance of the 2,000 smallest stocks in the Russell 3000 Index, representing a broad segment of small-cap U.S. companies.
Metrics and analysis →Unlock Your XBI Trading Now
Take control of your trading with ohlcx.com. Our platform offers unparalleled analysis and technical support for XBI, designed to enhance your market performance. Start optimizing your trades today and experience the difference with our expert tools!
Disclaimers
The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.
With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.
Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.
Securities products are: Not FDIC insured · Not bank guaranteed · May lose value
Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.